Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-24-042244
Filing Date
2024-09-27
Accepted
2024-09-27 19:56:26
Documents
1
Group Members
ATAI LIFE SCIENCES AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ef20036450_sc13da.htm SC 13D/A 67200
  Complete submission text file 0001140361-24-042244.txt   69077
Mailing Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT
Business Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT 1-716-676-6461
COMPASS Pathways plc (Subject) CIK: 0001816590 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92194 | Film No.: 241336299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filed by) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)